Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System |
Umthong, Supawadee
(Interdisciplinary Program in Medical Microbiology, Graduate School, Chulalongkorn University)
Buaklin, Arun (Department of Microbiology, Faculty of Medicine, Chulalongkorn University) Jacquet, Alain (Chulalongkorn University Vaccine Research Center, Chulalongkorn University) Sangjun, Noppadol (Armed Forces Research Institute of Medical Sciences) Kerdkaew, Ruthairat (Interdisciplinary Program in Medical Microbiology, Graduate School, Chulalongkorn University) Patarakul, Kanitha (Interdisciplinary Program in Medical Microbiology, Graduate School, Chulalongkorn University) Palaga, Tanapat (Interdisciplinary Program in Medical Microbiology, Graduate School, Chulalongkorn University) |
1 | Yan W Faisal SM McDonough SP Chang CF Pan MJ Akey B, Chang YF. 2010. Identification and characterization of OmpA-like proteins as novel vaccine candidates for leptospirosis. Vaccine 28: 2277-2283. DOI ScienceOn |
2 | Srikram A, Zhang K, Bartpho T, Lo M, Hoke DE, Sermswan RW, et al. 2011. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J. Infect. Dis. 203: 870-879. DOI ScienceOn |
3 | van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. 2001. Chitosan for mucosal vaccination. Adv. Drug Deliv. Rev. 52: 139-144. DOI ScienceOn |
4 | Wang S, Pal R, Mascola JR, Chou TH, Mboudjeka I, Shen S, et al. 2006. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 350: 34-47. DOI ScienceOn |
5 | Wang S, Parker C, Taaffe J, Solorzano A, Garcia-Sastre A, Lu S. 2008. Heterologous HA DNA vaccine prime - inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26: 3626-3633. DOI ScienceOn |
6 | Zuerner RL Alt DP Palmer MV Thacker TC Olsen SC. 2011. A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization. Clin. Vaccine Immunol. 18: 684-691. DOI |
7 | Monahan AM, Callanan JJ, Nally JE. 2008. Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect. Immun. 76: 4952-4958. DOI ScienceOn |
8 | Murray GL. 2013. The lipoprotein LipL32, an enigma of leptospiral biology. Vet. Microbiol. 162: 305-314. DOI ScienceOn |
9 | Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. 2001. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect. Immun. 69: 7550-7558. DOI ScienceOn |
10 | Nally JE, Whitelegge JP, Bassilian S, Blanco DR, Lovett MA. 2007. Characterization of the outer membrane proteome of Leptospira interrogans expressed during acute lethal infection. Infect. Immun. 75: 766-773. DOI ScienceOn |
11 | Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, et al. 2007. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26: 88-95. DOI ScienceOn |
12 | Picardeau M, Bulach DM, Bouchier C, Zuerner RL, Zidane N, Wilson PJ, et al. 2008. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 3: e1607. DOI ScienceOn |
13 | Pinne M, Haake DA. 2013. LipL32 is a subsurface lipoprotein of Leptospira interrogans: presentation of new data and reevaluation of previous studies. PLoS One 8: e51025. DOI |
14 | Ristow P, Bourhy P, da Cruz McBride FW, Figueira CP, Huerre M, Ave P, et al. 2007. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog. 3: e97. DOI ScienceOn |
15 | Harari A, Bart PA, Stohr W, Tapia G, Garcia M, Medjitna-Rais E, et al. 2008. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205: 63-77. DOI ScienceOn |
16 | Herrmann JL, Bakoss P, Korver H, Bulu AA, Bellenger E, Terpstra WJ, et al. 1994. A new serovar in the Grippotyphosa serogroup comprising leptospiral isolates from different regions. Int. J. Syst. Bacteriol. 44: 362-364. DOI |
17 | Koizumi N Watanabe H. 2003. Molecular cloning and characterization of a novel leptospiral lipoprotein with OmpA domain. FEMS Microbiol. Lett. 226: 215-219. DOI ScienceOn |
18 | Herrmann JL, Baril C, Bellenger E, Perolat P, Baranton G, Saint Girons I. 1991. Genome conservation in isolates of Leptospira interrogans. J. Bacteriol. 173: 7582-7588. DOI |
19 | Jost BH, Adler B, Vinh T, Faine S. 1986. A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis. J. Med. Microbiol. 22: 269-275. DOI |
20 | Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, et al. 2001. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release 70: 399-421. DOI ScienceOn |
21 | Lu S. 2009. Heterologous prime-boost vaccination. Curr. Opin. Immunol. 21: 346-351. DOI ScienceOn |
22 | Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, Scanga C, et al. 2008. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS One 3: e3790. DOI ScienceOn |
23 | McBride AJ, Athanazio DA, Reis MG, Ko AI. 2005. Leptospirosis. Curr. Opin. Infect. Dis. 18: 376-386. DOI ScienceOn |
24 | Cui Z, Mumper RJ. 2001. Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release 75: 409-419. DOI ScienceOn |
25 | Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B. 2002. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect. Immun. 70: 2311-2318. DOI |
26 | Haake DA Chao G Zuerner RL Barnett JK Barnett D Mazel M, et al. 2000. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect. Immun. 68: 2276-2285. DOI ScienceOn |
27 | Feng CY, Li QT, Zhang XY, Dong K, Hu BY, Guo XK. 2009. Immune strategies using single-component LipL32 and multi-component recombinant LipL32-41-OmpL1 vaccines against Leptospira. Braz. J. Med. Biol. Res. 42: 796-803. DOI |
28 | Guerreiro H, Croda J, Flannery B, Mazel M, Matsunaga J, Galvao Reis M, et al. 2001. Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect. Immun. 69: 4958-4968. DOI ScienceOn |
29 | Hall J, Hazlewood GP, Surani MA, Hirst BH, Gilbert HJ. 1990. Eukaryotic and prokaryotic signal peptides direct secretion of a bacterial endoglucanase by mammalian cells. J. Biol. Chem. 265: 19996-19999. |
30 | Haake DA Mazel MK McCoy AM Milward F Chao G Matsunaga J, Wagar EA. 1999. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect. Immun. 67: 6572-6582. |
31 | Haake DA, Suchard MA, Kelley MM, Dundoo M, Alt DP, Zuerner RL. 2004. Molecular evolution and mosaicism of leptospiral outer membrane proteins involves horizontal DNA transfer. J. Bacteriol. 186: 2818-2828. DOI |
32 | Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, et al. 2011. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat. Med. 17: 189-194. DOI ScienceOn |
33 | Adler B, de la Pena Moctezuma A. 2010. Leptospira and leptospirosis. Vet. Microbiol. 140: 287-296. DOI ScienceOn |
34 | Bolin CA, Cassells JA, Zuerner RL, Trueba G. 1991. Effect of vaccination with a monovalent Leptospira interrogans serovar Hardjo type Hardjo-Bovis vaccine on type Hardjo-Bovis infection of cattle. Am. J. Vet. Res. 52: 1639-1643. |
35 | Alpar HO, Bramwell VW. 2002. Current status of DNA vaccines and their route of administration. Crit. Rev. Ther. Drug Carrier Syst. 19: 307-383. DOI |
36 | Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3: 757-771. DOI ScienceOn |
37 | Coffman RL, Sher A, Seder RA. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503. DOI ScienceOn |
38 | Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, Andre-Fontaine G. 2005. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1. Infect. Immun. 73: 4062-4069. DOI ScienceOn |
39 | Branger C, Sonrier C, Chatrenet B, Klonjkowski B, Ruvoen-Clouet N, Aubert A, et al. 2001. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect. Immun. 69: 6831-6838. DOI ScienceOn |
40 | Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465-1468. DOI |
![]() |